After days of speculation, Germany's Merck KGaA has finally come out and confirmed that it is indeed looking at the possibility of selling its generics unit.The Darmstadt-based company issued a statement saying that it evaluating the divestiture of Merck Generics "as one strategic option," although it "is not engaged in initial discussions with any potential buyers."
Meanwhile, the billionaire founder of Serono, bought by Merck in a $13.3 billion deal last year, wants to get back into the health technology industry and considers Italy interesting, he told Il Sole 24 Ore newspaper.
"I would like to be involved in the health technology industry in the future," Ernesto Bertarelli said in an interview published on Sunday.
"I would say it's certainly a possibility (to invest in Italy) ... Italy continues to interest me a lot," he said.
Meanwhile, the billionaire founder of Serono, bought by Merck in a $13.3 billion deal last year, wants to get back into the health technology industry and considers Italy interesting, he told Il Sole 24 Ore newspaper.
"I would like to be involved in the health technology industry in the future," Ernesto Bertarelli said in an interview published on Sunday.
"I would say it's certainly a possibility (to invest in Italy) ... Italy continues to interest me a lot," he said.
1 comment:
Founder isn't really an accurate term; Bertarelli took over the family business.
Post a Comment